72903-853-01 : NDC 2026 Code

72903-853-01 : Mirvetuximab Soravtansine ( Elahere )

Additionally :

You can get information about “72903-853-01” NDC code in 72903-853-01 in HTML format

HTML | 72903-853-01 in TXT (Plain Text) format

TXT | 72903-853-01 in PDF (Portable Document Format)

PDF | 72903-853-01 in XML format

XML formats.

NDC Code : 72903-853-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72903-853-01",
    "PackageDescription": "1 VIAL, SINGLE-USE in 1 CARTON (72903-853-01)  / 20 mL in 1 VIAL, SINGLE-USE",
    "NDC11Code": "72903-0853-01",
    "ProductNDC": "72903-853",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Elahere",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Mirvetuximab Soravtansine",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20221114",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761310",
    "LabelerName": "ImmunoGen, Inc.",
    "SubstanceName": "MIRVETUXIMAB SORAVTANSINE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": null,
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-24",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20221114",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}